These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 25727392)
1. Phenprobamate dependence: a case report. Demir B; Demir Y; Aksoy I; Kilic OH; Gucyetmez V; Savas HA Addict Behav; 2015 Jun; 45():232-3. PubMed ID: 25727392 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of phenprobamate after oral administration to healthy subjects. Tulunay FC; Onaran HO; Ergün H; Ucar A; Usanmaz S; Embil K; Tulunay M Arzneimittelforschung; 1998 Nov; 48(11):1068-71. PubMed ID: 9850426 [TBL] [Abstract][Full Text] [Related]
4. [Centrally acting muscle relaxants and traffic hazards]. Bramness JG; Skurtveit S; Grung M; Mørland J Tidsskr Nor Laegeforen; 2000 Jun; 120(17):1966-9. PubMed ID: 11008526 [TBL] [Abstract][Full Text] [Related]
5. Carisoprodol: update on abuse potential and legal status. Reeves RR; Burke RS; Kose S South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807 [TBL] [Abstract][Full Text] [Related]
6. The occurrence of 3-hydroxy-phenprobamate, a new metabolite of phenprobamate, in dogs and humans. Farrier DS Arzneimittelforschung; 1975 May; 25(5):813-7. PubMed ID: 1242331 [TBL] [Abstract][Full Text] [Related]
7. Carisoprodol withdrawal after internet purchase. Eleid MF; Krahn LE; Agrwal N; Goodman BP Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent absorption of phenprobamate following multiple dosing in rats. Sun JX; Embil K; Lee CS Pharm Res; 1988 Jun; 5(6):387-90. PubMed ID: 3244651 [TBL] [Abstract][Full Text] [Related]
9. Impairment due to intake of carisoprodol. Bramness JG; Skurtveit S; Mørland J Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209 [TBL] [Abstract][Full Text] [Related]
13. Carisoprodol: a drug of continuing abuse. Reeves RR; Pinkofsky HB; Carter OS J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144 [TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic analysis, plasma protein binding and red blood cell partitioning of phenprobamate. Sun JX; Embil K; Chow DS; Lee CC Biopharm Drug Dispos; 1987; 8(4):341-51. PubMed ID: 3620593 [TBL] [Abstract][Full Text] [Related]
15. Is the frequency of carisoprodol withdrawal syndrome increasing? Reeves RR; Hammer JS; Pendarvis RO Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902 [TBL] [Abstract][Full Text] [Related]
16. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. Bramness JG; Furu K; Skurtveit S; Engeland A Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620 [TBL] [Abstract][Full Text] [Related]
17. Abuse of combinations of carisoprodol and tramadol. Reeves RR; Liberto V South Med J; 2001 May; 94(5):512-4. PubMed ID: 11372804 [TBL] [Abstract][Full Text] [Related]
18. Carisoprodol, meprobamate, and driving impairment. Logan BK; Case GA; Gordon AM J Forensic Sci; 2000 May; 45(3):619-23. PubMed ID: 10855968 [TBL] [Abstract][Full Text] [Related]
19. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data. Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478 [TBL] [Abstract][Full Text] [Related]
20. Carisoprodol (Soma): a new and cautious perspective on an old agent. Littrell RA; Hayes LR; Stillner V South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]